Cardiothoracic & vascular anesthesia

Hydroxocobalamin Versus Methylene Blue for the Treatment of Vasoplegic Shock Associated With Cardiopulmonary Bypass

J Cardiothorac Vasc AnesthPublished Retrospective cohort study

Authors' conclusion

Hydroxocobalamin was associated with a greater reduction in vasopressor requirements than methylene blue in treating VS associated with cardiopulmonary bypass.

Study context

Population
Adult cardiothoracic surgery patients with vasoplegic shock associated with CPB
Participants
120 patients
Exposure
Hydroxocobalamin vs methylene blue
  • Hydroxocobalaminn = 77
  • Methylene bluen = 43reference
Outcome
Change in vasopressor requirements (1, 3, 6, 12 and 24 hours after initiation)
Follow-up
First 24 hours
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Vasopressor requirements (norepinephrine equivalent) · hour 1
GroupValueBaseline
Hydroxocobalaminmean 0.27 (95% CI 0.21–0.33) µg/kg/min0.34 µg/kg/min (95% CI 0.28-0.4)
Methylene bluemean 0.44 (95% CI 0.38–0.51) µg/kg/min0.59 µg/kg/min (95% CI 0.52-0.66)

Value

Hydroxocobalaminmean 0.27 (95% CI 0.21–0.33) µg/kg/min
Methylene bluemean 0.44 (95% CI 0.38–0.51) µg/kg/min

Baseline

Hydroxocobalamin0.34 µg/kg/min (95% CI 0.28-0.4)
Methylene blue0.59 µg/kg/min (95% CI 0.52-0.66)
  • Hydroxocobalamin vs Methylene blue: P < 0.001 — hour 1

Observational data: associations, not effects.

Secondary outcomes

MAP · hour 1

P < 0.001

Baseline Hydroxocobalamin 65 mmHg (95% CI 63-67) · Methylene blue 57 mmHg (95% CI 54-59)

  • Mean arterial pressure (MAP): baseline difference p < 0.001

MAP · hour 1

MAP increased significantly from baseline at each time point within each group
Significantly greater increase in MAP with hydroxocobalamin after adjustment for baseline characteristics

Original publication

Hydroxocobalamin Versus Methylene Blue for the Treatment of Vasoplegic Shock Associated With Cardiopulmonary Bypass. J Cardiothorac Vasc Anesth. Published 19 July 2023. doi:10.1053/j.jvca.2023.07.015

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.